21 – 30 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Social, cultural and economic aspects of antimicrobial resistance
(
- Contribution to journal › Article
-
Mark
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
(
- Contribution to journal › Article
-
Mark
ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19
(
- Contribution to journal › Article
-
Mark
Applying the Proportionality Principle to COVID-19 Antibody Testing
2020) In Journal of Law and the Biosciences(
- Contribution to journal › Article
-
Mark
When does stand-alone software qualify as a medical device in the European Union?: The CJEU decision in SNITEM and what it implies for the next generation of medical devices
(
- Contribution to journal › Article
-
Mark
Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care
2020) p.295-336(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
2020)(
- Other contribution › Miscellaneous
-
Mark
Regulatory responses to medical machine learning
(
- Contribution to journal › Article
-
Mark
Establishing the First International Genetic Discrimination Observatory
(
- Contribution to journal › Article
-
Mark
Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation
2020) In Science and Public Policy(
- Contribution to journal › Article